- In April 2024, Metrion Biosciences enhanced its High Throughput Screening (HTS) services by adding access to Enamine’s vast compound libraries. This collaboration will allow Metrion to offer greater flexibility and efficiency in screening and target identification. By utilizing Enamine’s largest compound library, researchers can access specialized screening sets for drug discovery, optimizing hit expansion and structure-activity relationship studies. This integration will improve diversity and cost-efficiency in drug development, allowing Metrion to support its global clients more effectively
- In February 2023, PerkinElmer launched the EnVision Nexus Multimode Plate Reader, a cutting-edge research and discovery tool designed to improve research workflows. This new multimode plate reader will enhance research efficiency and accelerate scientific discovery by providing precise and versatile detection capabilities across various research applications. The technology aims to streamline processes, offering faster and more reliable results that can drive innovation in drug discovery, disease research, and other scientific fields
Frequently Asked Questions
The primary challenges include high initial setup costs and data management and analysis complexity.
The reagents and assay kits segment are expected to dominate the global high throughput screening market, holding a major market share in 2025.
